Business Description
Radnostix Inc
NAICS : 325412
SIC : 2834
ISIN : US45972C1027
Total Employee Number:
45Description
Radnostix Inc manufactures a wide range of radioisotope-focused products used in a variety of medical and industrial applications. The company produces generic sodium iodide I-131 drug product, produces a variety of cobalt-60 products, and is in development to manufacture and sell medical devices for the nuclear medicine industry. Its business consists of five reportable segments, which include: Theranostics Products, Cobalt Products, Calibration & Reference Products, Medical Devices, and Fluorine Products. The majority of the revenue is derived from the Theranostics Products segment, which produces and distributes various isotopically pure radiopharmaceuticals, APIs, and radiochemicals for medical, industrial, and research applications.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | 0.15 | |||||
Debt-to-Equity | 1.79 | |||||
Debt-to-EBITDA | -3.42 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -8.7 | |||||
Beneish M-Score | -3.59 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.4 | |||||
3-Year Book Growth Rate | -4.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.94 | |||||
9-Day RSI | 45.8 | |||||
14-Day RSI | 46.44 | |||||
3-1 Month Momentum % | -3.13 | |||||
6-1 Month Momentum % | 31.33 | |||||
12-1 Month Momentum % | 0.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.88 | |||||
Quick Ratio | 0.69 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 56.25 | |||||
Days Sales Outstanding | 48.33 | |||||
Days Payable | 79.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | -1.26 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 55.87 | |||||
Operating Margin % | -18.03 | |||||
Net Margin % | -17.56 | |||||
EBITDA Margin % | -11.34 | |||||
FCF Margin % | -0.46 | |||||
OCF Margin % | 4.54 | |||||
ROE % | -56.3 | |||||
ROA % | -12.19 | |||||
ROIC % | -15.4 | |||||
3-Year ROIIC % | 13.82 | |||||
ROC (Joel Greenblatt) % | -25.77 | |||||
ROCE % | -13.24 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 1 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
PS Ratio | 3.04 | |||||
PB Ratio | 14 | |||||
Price-to-Operating-Cash-Flow | 35 | |||||
EV-to-EBIT | -22.42 | |||||
EV-to-EBITDA | -29.2 | |||||
EV-to-Revenue | 3.31 | |||||
EV-to-FCF | -721.75 | |||||
Price-to-GF-Value | 1.4 | |||||
Price-to-Median-PS-Value | 1 | |||||
Earnings Yield (Greenblatt) % | -4.46 | |||||
FCF Yield % | -0.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:INIS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Radnostix Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 12.21 | ||
| EPS (TTM) ($) | - | ||
| Beta | 0.2044 | ||
| 3-Year Sharpe Ratio | 0.42 | ||
| 3-Year Sortino Ratio | 0.75 | ||
| Volatility % | 111.13 | ||
| 14-Day RSI | 46.44 | ||
| 14-Day ATR ($) | 0.006477 | ||
| 20-Day SMA ($) | 0.07238 | ||
| 12-1 Month Momentum % | 0.11 | ||
| 52-Week Range ($) | 0.0453 - 0.11 | ||
| Shares Outstanding (Mil) | 529.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Radnostix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Radnostix Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 131 days | ||
| Second quarter earnings results for 2026 | 2026-08-13 | In 39 days | ||
| General meeting for 2026 | 2026-07-16 14:00 | In 12 days | ||
| First quarter earnings results for 2026 | 2026-05-20 | 0.08 (+2.34%) | ||
| Annual report for 2025 | 2026-03-31 | 0.07 (-12.50%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 0.08 (+5.32%) | ||
| Second quarter earnings results for 2025 | 2025-08-13 | 0.11 (-0.09%) | ||
| General meeting for 2025 | 2025-07-10 14:00 | 0.08 (+18.71%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 0.04 (-10.95%) | ||
| Annual report for 2024 | 2025-03-04 | 0.04 (+6.67%) |
Show
Entries
Radnostix Inc Frequently Asked Questions
What is Radnostix Inc(INIS)'s stock price today?
The current price of INIS is $0.07. The 52 week high of INIS is $0.11 and 52 week low is $0.05.
When is next earnings date of Radnostix Inc(INIS)?
The next earnings date of Radnostix Inc(INIS) is 2026-08-13 Est..
Does Radnostix Inc(INIS) pay dividends? If so, how much?
Radnostix Inc(INIS) does not pay dividend.
Guru Commentaries on OTCPK:INIS
No articles.
Press Release
Articles on Radnostix Inc
No articles.